This company provides a MultiomicsAI platform and data interpretation framework to integrate biological context into pipeline decisions. The platform links diverse private and public bio data sources, including molecular, genetic, and proteomic data, at scale. This capability de-risks research findings and accelerates early-phase discovery timelines by streamlining data analysis.
Funding
$10K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Integrating diverse biomedical data assets in early-phase research is challenging, hindering the robustness of research findings. Analyzing Multiomics data is complex and costly, leading to delays in identifying key insights.
Solution
Knowing01 provides a software platform that contextualizes and links diverse biomedical data, enhancing the reliability of early-phase research. The platform utilizes proprietary Cellmap technology to radically expand the search space by finding, accessing, and linking relevant data of any bio type. By seamlessly blending coding and non-coding genes, genetics and proteomics, and mouse and human data, Knowing01 offers mind-blowing flexibility. The solution unlocks both private and public data sources, preparing users for analysis within days.
Target Audience
Knowing01's primary customers are Biotechs involved in early-phase drug discovery and research.
Features
- Cellmap technology for linking and contextualizing diverse biomedical data types
- Seamless integration of Multiomics data, including genomics, proteomics, and more
- Access to both private and public data sources
- Flexible data blending between coding and non-coding genes, genetics and proteomics, and mouse and human data
- Ability to radically expand the search space for relevant data